Release of replication-deficient retroviruses from a packaging cell line: Interaction with glioma tumor spheroids in vitro

International Journal of Cancer

Volumn 71, Issue 5, 1997, Pages 874-880

  Thorsen, Frits ^a   Visted, Therese ^a   Lehtolainen, Paulina ^b   Ylä Herttuala, Seppo ^b   Bjerkvig, Rolf ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; TUMOR SPHEROID;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; CELL AGGREGATION; CELL LINE; CELL SURVIVAL; COCULTURE TECHNIQUES; DNA; ESCHERICHIA COLI; FLOW CYTOMETRY; GLIOMA; HUMANS; MICE; RABBITS; RATS; RETROVIRIDAE; SPHEROIDS, CELLULAR; TRANSFECTION; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0030922195     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970529)71:5<874::AID-IJC28>3.0.CO;2-6     Document Type: Article

References (38)

1. AKSLEN, L.A., ANDERSEN, K.J. and BJERKVIG, R., Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res., 8, 797-804 (1988).
2. ANDERSON, T.F., Techniques for the preservation of three-dimensional structure in preparing specimens for the electron microscope. Trans. N.Y. Acad. Sci., 13, 130-133 (1951).
3. AVALOSSE, B., DUPONT, F. and BURNY, A., Gene therapy for cancer. Curr. Opin. Oncol., 7, 94-100 (1995).
4. BAISCH, H., GÖHDE, W. and LINDEN, W.A., Analysis of PCP data to determine the fraction of cells in the various phases of the cell cycle. Radiat. Environ. Biophys., 12, 31-39 (1975).
5. BJERKVIG, R., Reaggregation of fetal brain cells in a stationary culture system. II: Ultrastructural characterization. In Vitro cell. der. Biol., 22, 193-200 (1986).
6. BJERKVIG, R., STEINSVÅG, S.K. and LAERUM, O.D., Reaggregation of fetal rat brain cells in a stationary culture system. I: Methodology and cell identification. In Vitro cell. dev. Biol., 22, 180-192 (1986).
7. BLAESE, R.M. and 18 OTHERS, T-lymphocyte-directed gene therapy for ADA SCID: initial trial results after 4 years. Science, 270, 475-480 (1995).
8. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKEFIEED, X.O. and CHIOCCA, E.A., Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes-simplex-virus vector that retains an intact thymidine-kinase gene. Cancer Res., 54, 5745-5751 (1994).
9. CHAMBERS, R., GILLESPIE, G.Y., SOROCEANU, L., ANDREANSKYm S., CHATTERJEE, S., CHOU, J., ROIZMAN, B. and WHITLEY, R.J., Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumours in a SCID mouse model of human malignant glioma. Proc. nat. Acad. Sci. (Wash.), 92, 1411-1415 (1995).
10. CONN, P.M., Methods in neurosciences, pp. 367-392, Academic Press, New York (1989).
11. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H. and BLAESE, R.M., In vivo gene transfer with retroviral-vector-producer cells for treatment of experimental brain tumors. Science, 256, 1550-1552 (1992).
12. DRUCKREY, H., Genotypes and phenotypes of ten inbred strains of BD rats. Arzneim Forsch., 21, 1274-1278 (1971).
13. ELLISON, B.J. and RUBIN, H., Individual transforming events in long-term culture of NIH 3T3 cells as products of epigenic induction. Cancer Res., 52, 667-673 (1992).
14. FRESHNEY, R.I., Culture of animal cells. J. Wiley, New York (1994).
15. GORDON, E.M. and ANDERSON, W.F., Gene therapy using retro viral vectors. Curr. Opin. Biotechnol., 5, 611-616 (1994).
16. HONIG, M.G. and HUME, R.I., Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures. J. Cell Biol., 103, 171-187 (1986).
17. IZQUIERDO, M., CORTÈS, M., DE FELIPE, P., MARTÍN, V. DÍEZ-GUERRA, J., TALAVERA, A. and PEREZ-HIGUERAS, P., Long-term rat survival after malisnant-brain-tumor regression by retroviral gene therapy. Gene Then., 2, 66-69 (1995).
18. KALNINS, A., OTTO, K., RÜTHER, O.K. and MÜLLER-HILL, B., Sequence of the lacZ gene of Escherichia coli. EMBO J., 2, 593-597 (1983).
19. KORNBLITH, P.K., WELCH, W.C. and BRADLEY, M.K., The future of therapy for glioblastoma. Surg. Neurol., 39, 538-543 (1993).
20. LEVINE, F. and FRIEDMANN, T., Gene therapy techniques. Curr. Opin. Biotechnol., 2, 840-844 (1991).
21. LOTZE, M.T. and RUBIN, J.T., Clinical protocol: gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum. Gene Then, 5, 41-55 (1994).
22. LUND-JOHANSEN, M., BJERKVIG, R. and ANDERSEN, K.J., Multicellular tumor spheroids in chemically defined culture. Anticancer Res., 9, 413-420 (1989).
23. MANN, R., MULLIGAN, R.C. and BALTIMORE, D., Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33, 153-159 (1983).
24. MILLER, A.D. and BUTTIMORE, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. cell. Biol., 6, 2895-2902 (1986).
25. MINETA, T., RABKIN, S.D. and MARTUZA, R.L., Treatment of malignant gliomas using ganciclovir-hypersensitive. ribonucleotide-reductase-deficient herpes simplex viral mutant. Cancer Res., 54, 3963-3966 (1994).
26. MIYANOHARA, A., SHARKEY, M.F., WITZTUM, J.L., STEINBERG, D. and FRIEDMANN, T., Efficient expression of retroviral-vector-transduced human low-density-lipoprotein (LDL) receptor in LDL-receptor-deficient rabbit fibroblasts in vitro. Proc. nat. Acad. Sci. (Wash.), 85, 6538-6542 (1988).
27. NABEL, G.J., Clinical protocol: immunotherapy for cancer by direct gene transfer into tumors. Hum. Gene Ther., 5, 57-77 (1994).
28. OLDFIELD, E.H., Clinical protocol: gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine-kinase gene and intravenous ganciclovir. Hum. Gene Ther., 4, 39-69 (1993).
29. RAFFEL, C. and CULVER, K., Clinical protocol: gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine-kinase gene/ganciclovir system. Hum. Gene Ther., 5, 863-890 (1994).
30. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M. and OLDFIELD, E.H., In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53, 83-88 (1993).
31. RAM, Z., WALBRIDGE, S., SHAWKER, T., CULVER, K.W., BLAESE, R.M. and OLDFIELD, E.H., The effect of thymidine-kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J. Neurosurg., 8, 256-260 (1994).
32. RUSSELL, D.S. and RUBINSTEIN, L.J., Pathology of tumours of the nervous system, E. Arnold, London (1989).
33. SHORT, M.P., CHOI, B.C., LEE, J.K., MALICK, A., BREAKEFIELD, X.O. and MARTUZA, R.L., Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J. Neurosci. Res., 27, 427-433 (1990).
34. WHARTENBY, K.A., ABRAHAM, G.N., CALABRESI, P.A., ABBOUD, C.N., CALABRESI, P., MARROGI, A. and FREEMAN, S.M., Gene-modified cells for the treatment of cancer. Pharmacol. Ther., 66, 175-190 (1995).
35. WU, J.K., CANO, W.G., MBYLAERTS, S.A.G., QI, P., VRIONIS, F. and CHERINGTON, V., Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery, 35, 1094-1103 (1994).
36. YAMADA, M., SHIMIZU, K., MIYAO, Y., HAYAKAWA, T., IKENAKA, K., NAKAHIRA, K., NAKAJIMA, K., KAGAWA, T. and MIKOSHIBA, K., Retrovirusmediated gene transfer targeted to malignant glioma cells in murine brain. Jap. J. Cancer Res., 83, 1244-1247 (1992).
37. YLÄ-HERTTUALA, S., LUOMA, J., VIITA, H., HILTUNEN, T., SISTO, T. and NIKKARI, T., Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low-density lipoprotein. J. clin. Invest., 95, 2692-2698 (1995).
38. YUHAS, J.M., Li, A.P., MARTINEZ, A.O. and LADMAN, A.J., A simplified method for production and growth of multicellular tumor spheroids. CancerRes., 37, 3639-3643 (1977).